Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAFTING: Radiation-Free Therapy for Early Hodgkin Lymphoma
NCT04866654Phase 2Recruiting
- Sponsor
- Medical University of Gdańsk
- Start
- Mar 2021
- Primary completion
- Sep 2022
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of nivolumab in classical Hodgkin lymphoma (cHL), sponsored by Medical University of Gdańsk. Started Mar 2021; status: recruiting.
02
Drugs
03
Conditions
classical Hodgkin lymphoma (cHL)
Beyond the preview
Go deeper on NCT04866654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04866654.